IDEX (NYSE:IEX – Get Free Report) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.200-2.250 for the period, compared to the consensus earnings per share estimate of 2.190. The company issued revenue guidance of -. IDEX also updated its FY 2026 guidance to 8.700-8.850 EPS.
IDEX Trading Up 2.8%
NYSE IEX traded up $6.35 during trading hours on Wednesday, reaching $231.00. The company had a trading volume of 848,942 shares, compared to its average volume of 769,791. The company has a current ratio of 3.39, a quick ratio of 2.40 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $17.10 billion, a P/E ratio of 34.14, a price-to-earnings-growth ratio of 2.20 and a beta of 0.98. The stock has a 50-day moving average of $219.84 and a 200 day moving average of $207.73. IDEX has a 1-year low of $157.25 and a 1-year high of $243.80.
IDEX (NYSE:IEX – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. The business had revenue of $920.60 million during the quarter, compared to analysts’ expectations of $905.38 million. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the business earned $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. As a group, research analysts anticipate that IDEX will post 8.48 earnings per share for the current fiscal year.
IDEX Announces Dividend
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on IEX. Robert W. Baird set a $257.00 target price on IDEX in a research report on Thursday, April 30th. Seaport Research Partners reaffirmed a “buy” rating and issued a $250.00 price objective on shares of IDEX in a research note on Tuesday, May 5th. TD Cowen increased their target price on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Royal Bank Of Canada raised their target price on IDEX from $252.00 to $261.00 and gave the company an “outperform” rating in a report on Thursday, July 16th. Finally, Weiss Ratings raised IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, June 24th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.00.
Insiders Place Their Bets
In other IDEX news, CEO Eric D. Ashleman sold 15,385 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $215.22, for a total value of $3,311,159.70. Following the sale, the chief executive officer owned 66,658 shares of the company’s stock, valued at $14,346,134.76. This trade represents a 18.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is currently owned by company insiders.
Key IDEX News
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Quarterly results exceeded expectations. IDEX reported adjusted earnings of $2.32 per share, above the $2.11 consensus estimate and up from $2.07 a year earlier. Revenue reached $920.6 million, topping the $905.4 million estimate and increasing 6.4% year over year. IDEX quarterly earnings report
- Positive Sentiment: Demand indicators were particularly strong. Orders rose 29% on a reported basis, or 28% organically, to a record $1.07 billion. The company also reported $143.4 million in net income, compared with $131.6 million in the prior-year quarter, while diluted EPS increased 11% to $1.93. IDEX Q2 sales rise to record $921 million
- Positive Sentiment: Management raised its outlook. Full-year 2026 adjusted EPS guidance was set at $8.70–$8.85, above the $8.49 analyst consensus, while third-quarter guidance of $2.20–$2.25 also exceeded the $2.19 estimate. Full-year organic sales growth is projected at 5%–6%.
- Positive Sentiment: IDEX returned capital to shareholders through $77 million of share repurchases and $54 million in dividends, supporting the investment case.
- Neutral Sentiment: Analysts maintained an overall “Moderate Buy” consensus, while institutional ownership changes were mixed, with several large funds adding shares and others reducing or exiting positions. IDEX analyst recommendation
- Negative Sentiment: Insider activity was a modest caution: CEO Eric Ashleman sold 15,385 shares during the past six months and reported no purchases. The stock also trades at a relatively elevated valuation of roughly 34 times earnings, which could increase sensitivity to any slowdown.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC acquired a new position in shares of IDEX in the 2nd quarter valued at $35,000. MUFG Securities EMEA plc acquired a new stake in IDEX during the 2nd quarter worth $39,000. McMillan Office Inc. acquired a new stake in IDEX during the 4th quarter worth $46,000. Los Angeles Capital Management LLC purchased a new stake in IDEX in the fourth quarter valued at $57,000. Finally, Employees Retirement System of Texas acquired a new position in IDEX in the third quarter valued at $99,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.
About IDEX
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Read More
- Five stocks we like better than IDEX
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
- Meta’s AI Spending Problem Just Found a BlackRock Solution
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
